NCT06744465
NearWave Optical Molecular Monitoring
StatusActive, Not Recruiting
PhaseNot applicable
SponsorIndiana University
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 14 words
- Enrollment closed, study ongoing
- Final enrollment: 5 participants (planned 15)
- Site details revised
- Notable Primary and study completion dates: Jan 2026 to Jan 2027v5
- Minor Primary and study completion dates: Jul 2025 to Jan 2026v4
- Notable Phase: Not specified to Not applicable
- Start date changed from estimate of Mar 2025 to Mar 7, 2025
- Site contact updated
- Notable Trial status: Not Yet Recruiting to Recruiting
- Eligibility criteria expanded, about 7 words
- Start date: Jan 2025 to Mar 2025
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Feasibility of using NearWave imaging as a monitoring system
Timeframe: Over approximately 5 months; baseline, mid way through treatment, and at last dose of clinical chemotherapy/prior to clinical surgery
Arms and interventions
NearWave monitoringExperimental
Breast cancer patients receiving neoadjuvant chemotherapy treatment followed by surgery will be monitored by a noninvasive handheld imaging device before, during and after chemotherapy.
Devices: NearWave monitoring
Sites
1 site in 1 country
- Indiana University Simon Comprehensive Cancer CenterIndianapolis, Indiana, United States